吉贝尔：化学原料药加替沙星上市申请获批

Core Viewpoint - The company, Jibeier (688566), has received approval from the National Medical Products Administration for its chemical raw material, gatifloxacin, which is the main ingredient in its gatifloxacin eye drops used for treating acute bacterial conjunctivitis caused by sensitive bacteria [1] Group 1 - The approval notification is specifically for the chemical raw material drug application [1] - Gatifloxacin eye drops are primarily indicated for acute bacterial conjunctivitis [1]